-
1
-
-
0035102526
-
The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells
-
Kwak B, Mulhaupt F, Veillard N, Pelli G, Mach F. The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells. Swiss Med Wkly 2001, 131:41-46.
-
(2001)
Swiss Med Wkly
, vol.131
, pp. 41-46
-
-
Kwak, B.1
Mulhaupt, F.2
Veillard, N.3
Pelli, G.4
Mach, F.5
-
2
-
-
0032487931
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
-
Long Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
-
Long Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998, 339:1349-1357. Long Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.
-
(1998)
N Engl J Med
, vol.339
, pp. 1349-1357
-
-
-
3
-
-
0027987849
-
Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease
-
Scandinavian Simvastatin Survival Study Group
-
Scandinavian Simvastatin Survival Study Group Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994, 344:1383-1389. Scandinavian Simvastatin Survival Study Group.
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
4
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
-
10.1056/NEJM199610033351401, 8801446, Cole TG for the Cholesterol and Recurrent Events Trial Investigators
-
Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG for the Cholesterol and Recurrent Events Trial Investigators The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996, 335:1001-1009. 10.1056/NEJM199610033351401, 8801446, Cole TG for the Cholesterol and Recurrent Events Trial Investigators.
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
Rouleau, J.L.4
Rutherford, J.D.5
-
5
-
-
43049091905
-
Lipid-lowering medication use and aggression scores in women: a report from the NHLBI-sponsored WISE study
-
Olson MB, Kelsey SF, Matthews KA, Bairey MERZ N, Eteiba W, McGorray SP, Cornell CE, Vido DA, Muldoon MF. Lipid-lowering medication use and aggression scores in women: a report from the NHLBI-sponsored WISE study. J Womens Health 2008, 17:187-194.
-
(2008)
J Womens Health
, vol.17
, pp. 187-194
-
-
Olson, M.B.1
Kelsey, S.F.2
Matthews, K.A.3
Bairey Merz, N.4
Eteiba, W.5
McGorray, S.P.6
Cornell, C.E.7
Vido, D.A.8
Muldoon, M.F.9
-
6
-
-
0029739434
-
Serum cholesterol concentration and death from suicide in men: Paris prospective study I
-
10.1136/bmj.313.7058.649, 2351965, 8811757
-
Zureik M, Courbon D, Ducimetiere P. Serum cholesterol concentration and death from suicide in men: Paris prospective study I. BMJ 1996, 313:649-651. 10.1136/bmj.313.7058.649, 2351965, 8811757.
-
(1996)
BMJ
, vol.313
, pp. 649-651
-
-
Zureik, M.1
Courbon, D.2
Ducimetiere, P.3
-
7
-
-
0026601595
-
Low serum cholesterol and suicide
-
10.1016/0140-6736(92)90609-7, 1347593
-
Engelberg H. Low serum cholesterol and suicide. Lancet 1992, 339:727-729. 10.1016/0140-6736(92)90609-7, 1347593.
-
(1992)
Lancet
, vol.339
, pp. 727-729
-
-
Engelberg, H.1
-
8
-
-
0042230978
-
Long-term statin use and psychological well-being
-
10.1016/S0735-1097(03)00785-X, 2673913, 12932603
-
Young-Xu Y, Chan KA, Liao JK, Ravid S, Blatt CM. Long-term statin use and psychological well-being. J Am Coll Cardiol 2003, 42:690-697. 10.1016/S0735-1097(03)00785-X, 2673913, 12932603.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 690-697
-
-
Young-Xu, Y.1
Chan, K.A.2
Liao, J.K.3
Ravid, S.4
Blatt, C.M.5
-
9
-
-
0041335277
-
Behavioral implications of lowering cholesterol levels: a double-blind pilot study
-
10.1176/appi.psy.44.5.412, 12954916
-
Ormiston T, Wolkowitz OM, Reus VI, Manfredi F. Behavioral implications of lowering cholesterol levels: a double-blind pilot study. Psychosomatics 2003, 44:412-414. 10.1176/appi.psy.44.5.412, 12954916.
-
(2003)
Psychosomatics
, vol.44
, pp. 412-414
-
-
Ormiston, T.1
Wolkowitz, O.M.2
Reus, V.I.3
Manfredi, F.4
-
10
-
-
80053005570
-
The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression?
-
10.4088/JCP.09m05825blu, 21208591
-
Stafford L, Berk M. The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression?. J Clin Psychiatry 2011, 72:1229-1235. 10.4088/JCP.09m05825blu, 21208591.
-
(2011)
J Clin Psychiatry
, vol.72
, pp. 1229-1235
-
-
Stafford, L.1
Berk, M.2
-
11
-
-
84861828191
-
Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the heart and soul study
-
10.4088/JCP.11m07038, 22394433
-
Otte C, Zhao S, Whooley MA. Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the heart and soul study. J Clin Psychiatry 2012, 73:610-615. 10.4088/JCP.11m07038, 22394433.
-
(2012)
J Clin Psychiatry
, vol.73
, pp. 610-615
-
-
Otte, C.1
Zhao, S.2
Whooley, M.A.3
-
12
-
-
77955103866
-
Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression
-
10.1159/000319530, 20689351
-
Pasco JA, Jacka FN, Williams LJ, Henry MJ, Nicholson GC, Kotowicz MA, Berk M. Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression. Psychother Psychosom 2010, 79:323-325. 10.1159/000319530, 20689351.
-
(2010)
Psychother Psychosom
, vol.79
, pp. 323-325
-
-
Pasco, J.A.1
Jacka, F.N.2
Williams, L.J.3
Henry, M.J.4
Nicholson, G.C.5
Kotowicz, M.A.6
Berk, M.7
-
13
-
-
84861730748
-
The effects of statins on mood: a review of the literature
-
While A, Keen L. The effects of statins on mood: a review of the literature. Eur J Cardiovasc Nurs 2012, 11:85-96.
-
(2012)
Eur J Cardiovasc Nurs
, vol.11
, pp. 85-96
-
-
While, A.1
Keen, L.2
-
14
-
-
67650094615
-
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
-
10.1136/bmj.b2376, 2714690, 19567909
-
Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J, Westendorp RGJ, Craen AJ, Knopp RH, Nakamura H, Ridker P, van Domburg R, Deckers JW. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 2009, 338:b2376. 10.1136/bmj.b2376, 2714690, 19567909.
-
(2009)
BMJ
, vol.338
-
-
Brugts, J.J.1
Yetgin, T.2
Hoeks, S.E.3
Gotto, A.M.4
Shepherd, J.5
Westendorp, R.G.J.6
Craen, A.J.7
Knopp, R.H.8
Nakamura, H.9
Ridker, P.10
van Domburg, R.11
Deckers, J.W.12
-
15
-
-
70249094944
-
Statins for the primary prevention of cardiovascular disease
-
Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas J-P, Ebrahim S. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2011, 12:CD008203.
-
(2011)
Cochrane Database Syst Rev
, vol.12
-
-
Taylor, F.1
Ward, K.2
Moore, T.H.3
Burke, M.4
Davey Smith, G.5
Casas, J.-P.6
Ebrahim, S.7
-
16
-
-
0037102906
-
Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes
-
10.1002/sim.1205, 12210629
-
Curtin F, Altman DG, Elbourne D. Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes. Stat Med 2002, 21:2131-2144. 10.1002/sim.1205, 12210629.
-
(2002)
Stat Med
, vol.21
, pp. 2131-2144
-
-
Curtin, F.1
Altman, D.G.2
Elbourne, D.3
-
17
-
-
0026776749
-
Variance imputation for overviews of clinical trials with continuous response
-
10.1016/0895-4356(92)90054-Q, 1619456
-
Follmann D, Elliot P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 1992, 45:769-773. 10.1016/0895-4356(92)90054-Q, 1619456.
-
(1992)
J Clin Epidemiol
, vol.45
, pp. 769-773
-
-
Follmann, D.1
Elliot, P.2
Suh, I.3
Cutler, J.4
-
18
-
-
21544449115
-
Estimating the mean and variance from the median, range, and the size of a sample
-
10.1186/1471-2288-5-13, 1097734, 15840177
-
Hozo S, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005, 5:13. 10.1186/1471-2288-5-13, 1097734, 15840177.
-
(2005)
BMC Med Res Methodol
, vol.5
, pp. 13
-
-
Hozo, S.1
Djulbegovic, B.2
Hozo, I.3
-
19
-
-
0037295226
-
Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial
-
10.1016/S0306-4530(02)00014-8, 12510011
-
Hyyppa M, Kronholm E, Virtanen A, Leino A, Jula A. Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial. Psychoneuroendocrinology 2003, 28:181-194. 10.1016/S0306-4530(02)00014-8, 12510011.
-
(2003)
Psychoneuroendocrinology
, vol.28
, pp. 181-194
-
-
Hyyppa, M.1
Kronholm, E.2
Virtanen, A.3
Leino, A.4
Jula, A.5
-
20
-
-
0020959111
-
The Brief Symptom Inventory: an introductory report
-
10.1017/S0033291700048017, 6622612
-
Derogatis L, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983, 13:595-605. 10.1017/S0033291700048017, 6622612.
-
(1983)
Psychol Med
, vol.13
, pp. 595-605
-
-
Derogatis, L.1
Melisaratos, N.2
-
21
-
-
69449100622
-
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
-
10.1136/bmj.b2535, 2714657, 19622551
-
Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535. 10.1136/bmj.b2535, 2714657, 19622551.
-
(2009)
BMJ
, vol.339
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
Altman, D.4
-
22
-
-
85047692071
-
HMG CoA reductase inhibitors and quality of life
-
10.1001/jama.1993.03500240051020, 8505809, the Air Force Coronary Atherosclerosis Prevention Study Research G
-
Downs JR, Oster G, Santanello NC, the Air Force Coronary Atherosclerosis Prevention Study Research G HMG CoA reductase inhibitors and quality of life. JAMA 1993, 269:3107-3108. 10.1001/jama.1993.03500240051020, 8505809, the Air Force Coronary Atherosclerosis Prevention Study Research G.
-
(1993)
JAMA
, vol.269
, pp. 3107-3108
-
-
Downs, J.R.1
Oster, G.2
Santanello, N.C.3
-
23
-
-
0030017719
-
Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration
-
10.1136/bmj.313.7049.75, 2351518, 8688757
-
Wardle J, Armitage J, Collins R, Wallendszus K, Keech A, Lawson A. Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. BMJ 1996, 313:75-78. 10.1136/bmj.313.7049.75, 2351518, 8688757.
-
(1996)
BMJ
, vol.313
, pp. 75-78
-
-
Wardle, J.1
Armitage, J.2
Collins, R.3
Wallendszus, K.4
Keech, A.5
Lawson, A.6
-
24
-
-
0028352357
-
Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers
-
10.1111/j.1365-2125.1994.tb04268.x, 1364752, 8198930
-
Harrison RW, Ashton CH. Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers. Br J Clin Pharmacol 1994, 37:231-236. 10.1111/j.1365-2125.1994.tb04268.x, 1364752, 8198930.
-
(1994)
Br J Clin Pharmacol
, vol.37
, pp. 231-236
-
-
Harrison, R.W.1
Ashton, C.H.2
-
25
-
-
0028967918
-
Effects of treatment with lovastatin and pravastatin on daytime cognitive performance
-
10.1002/clc.4960180406, 7788948
-
Gengo F, Cwudzinski D, Kinkel P, Block G, Stauffer L, Lines C. Effects of treatment with lovastatin and pravastatin on daytime cognitive performance. Clin Cardiol 1995, 18:209-214. 10.1002/clc.4960180406, 7788948.
-
(1995)
Clin Cardiol
, vol.18
, pp. 209-214
-
-
Gengo, F.1
Cwudzinski, D.2
Kinkel, P.3
Block, G.4
Stauffer, L.5
Lines, C.6
-
26
-
-
0034645450
-
Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin
-
10.1001/archinte.160.20.3144, 11074745, for the LSI
-
Stewart RA, Sharples KJ, North FM, Menkes DB, Baker J, Simes J, for the LSI. Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. Arch Intern Med 2000, 160:3144-3152. 10.1001/archinte.160.20.3144, 11074745.
-
(2000)
Arch Intern Med
, vol.160
, pp. 3144-3152
-
-
Stewart, R.A.1
Sharples, K.J.2
North, F.M.3
Menkes, D.B.4
Baker, J.5
Simes, J.6
-
27
-
-
33645130549
-
Simvastatin causes changes in affective processes in elderly volunteers
-
10.1111/j.1532-5415.2005.00542.x, 16420200
-
Morales K, Wittink M, Datto C, DiFilippo S, Cary M, TenHave T, Katz IR. Simvastatin causes changes in affective processes in elderly volunteers. J Am Geriatr Soc 2006, 54:70-76. 10.1111/j.1532-5415.2005.00542.x, 16420200.
-
(2006)
J Am Geriatr Soc
, vol.54
, pp. 70-76
-
-
Morales, K.1
Wittink, M.2
Datto, C.3
DiFilippo, S.4
Cary, M.5
TenHave, T.6
Katz, I.R.7
-
28
-
-
0034015649
-
Effects of lovastatin on cognitive function and psychological well-being
-
10.1016/S0002-9343(00)00353-3, 10806282
-
Muldoon MF, Barger SD, Ryan CM, Flory JD, Lehoczky JP, Matthews KA, Manuck SB. Effects of lovastatin on cognitive function and psychological well-being. Am J Med 2000, 108:538-546. 10.1016/S0002-9343(00)00353-3, 10806282.
-
(2000)
Am J Med
, vol.108
, pp. 538-546
-
-
Muldoon, M.F.1
Barger, S.D.2
Ryan, C.M.3
Flory, J.D.4
Lehoczky, J.P.5
Matthews, K.A.6
Manuck, S.B.7
-
30
-
-
0033282727
-
Major depression and activation of the inflammatory response system
-
10.1007/978-0-585-37970-8_2, 10442165
-
Maes M. Major depression and activation of the inflammatory response system. Adv Exp Med Biol 1999, 461:25-46. 10.1007/978-0-585-37970-8_2, 10442165.
-
(1999)
Adv Exp Med Biol
, vol.461
, pp. 25-46
-
-
Maes, M.1
-
31
-
-
44249104471
-
Oxidative stress may be a common mechanism linking major depression and osteoporosis
-
Pasco J, Nicholson G, Ng F, Henry M, Williams L, Kotowicz M, Hodge J, Dodd S, Kapczinski F, Gama C, Berk M. Oxidative stress may be a common mechanism linking major depression and osteoporosis. Acta Neuropsychiatrica 2008, 20:112-116.
-
(2008)
Acta Neuropsychiatrica
, vol.20
, pp. 112-116
-
-
Pasco, J.1
Nicholson, G.2
Ng, F.3
Henry, M.4
Williams, L.5
Kotowicz, M.6
Hodge, J.7
Dodd, S.8
Kapczinski, F.9
Gama, C.10
Berk, M.11
-
32
-
-
84862769027
-
New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors
-
10.1007/s10787-011-0111-7, 22271002
-
Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology 2012, 20:127-150. 10.1007/s10787-011-0111-7, 22271002.
-
(2012)
Inflammopharmacology
, vol.20
, pp. 127-150
-
-
Maes, M.1
Fišar, Z.2
Medina, M.3
Scapagnini, G.4
Nowak, G.5
Berk, M.6
-
33
-
-
0042835785
-
Lipid-lowering drugs and the risk of depression and suicidal behavior
-
10.1001/archinte.163.16.1926, 12963565
-
Yang C, Jick S, Jick H. Lipid-lowering drugs and the risk of depression and suicidal behavior. Arch Intern Med 2003, 163:1926-1932. 10.1001/archinte.163.16.1926, 12963565.
-
(2003)
Arch Intern Med
, vol.163
, pp. 1926-1932
-
-
Yang, C.1
Jick, S.2
Jick, H.3
-
34
-
-
84863782852
-
Co-morbid cardiovascular disease and depression: sequence of disease onset is linked to mental but not physical self-rated health. Results from a cross-sectional, population-based study
-
10.1007/s00127-011-0421-5, 21830082
-
O'Neil A, Williams ED, Stevenson CE, Oldenburg B, Berk M, Sanderson K. Co-morbid cardiovascular disease and depression: sequence of disease onset is linked to mental but not physical self-rated health. Results from a cross-sectional, population-based study. Soc Psychiatry Psychiatr Epidemiol 2012, 47:1145-1151. 10.1007/s00127-011-0421-5, 21830082.
-
(2012)
Soc Psychiatry Psychiatr Epidemiol
, vol.47
, pp. 1145-1151
-
-
O'Neil, A.1
Williams, E.D.2
Stevenson, C.E.3
Oldenburg, B.4
Berk, M.5
Sanderson, K.6
-
35
-
-
23644457189
-
In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias
-
10.1016/j.jclinepi.2005.01.006, 16085192
-
Terrin N. In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol 2005, 58:894-901. 10.1016/j.jclinepi.2005.01.006, 16085192.
-
(2005)
J Clin Epidemiol
, vol.58
, pp. 894-901
-
-
Terrin, N.1
|